Thermo Fisher Scientific Inc.
TMO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $198,728 | $204,885 | $215,870 | $262,893 |
| - Cash | $4,009 | $8,083 | $8,524 | $4,477 |
| + Debt | $32,775 | $36,424 | $36,073 | $36,339 |
| Enterprise Value | $227,494 | $233,226 | $243,419 | $294,755 |
| Revenue | $42,879 | $42,857 | $44,915 | $39,211 |
| % Growth | 0.1% | -4.6% | 14.5% | – |
| Gross Profit | $17,728 | $17,194 | $19,011 | $19,634 |
| % Margin | 41.3% | 40.1% | 42.3% | 50.1% |
| EBITDA | $11,800 | $11,195 | $11,942 | $11,969 |
| % Margin | 27.5% | 26.1% | 26.6% | 30.5% |
| Net Income | $6,335 | $5,995 | $6,950 | $7,725 |
| % Margin | 14.8% | 14% | 15.5% | 19.7% |
| EPS Diluted | 16.53 | 15.45 | 17.64 | 19.46 |
| % Growth | 7% | -12.4% | -9.4% | – |
| Operating Cash Flow | $8,667 | $8,406 | $9,154 | $9,543 |
| Capital Expenditures | -$1,400 | -$1,479 | -$2,243 | -$2,523 |
| Free Cash Flow | $7,267 | $6,927 | $6,911 | $7,020 |